Platinum-etoposide chemotherapy
WebbSafety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease The combination of platinum agents plus etoposide …
Platinum-etoposide chemotherapy
Did you know?
Webb6 apr. 2024 · First-line chemoimmunotherapy was administered as early as possible after diagnosis: four to six cycles of etoposide plus carboplatin or cisplatin combined with … Webb11 apr. 2024 · BackgroundThere are a variety of treatment options for recurrent platinum-resistant ovarian cancer, and the optimal specific treatment still remains to be determined. Therefore, this Bayesian network meta-analysis was conducted to investigate the optimal treatment options for recurrent platinum-resistant ovarian cancer.MethodsPubmed, …
WebbThe dose-reduced chemotherapy with first-line etoposide plus platinum had non-inferior survival outcomes compared to the full-dose chemotherapy in elderly patients with ED … Webb18 juli 2024 · For over 30 years, platinum-based chemotherapy has remained the primary therapeutic option for patients with SCLC. The recent CASPIAN and IMpower133 studies on the effectiveness of the combination of chemotherapy and immunotherapy in this group of patients have opened a completely new chapter in SCLC treatment.
WebbBackground: Patients with limited-stage (ls) or extensive-stage (es) small-cell lung cancer (sclc) are commonly given platinum-based chemotherapy as first-line treatment. Standard chemotherapy for patients with ls sclc includes a platinum agent such as cisplatin combined with the non-platinum agent etoposide. Webb1 dec. 2024 · Methods Five consecutive ACC patients treated with platinum etoposide (120-150 mg/m2 day 1-2-3 at cycle 1), with or without concomitant mitotane, were …
Webb1 juli 2024 · Currently, programmed death-ligand 1 (PD-L1) inhibitor plus platinum-etoposide chemotherapy has been recognized as a standard treatment for patients with ES-SCLC in a first-line setting. 7,8 To date, there are no reports evaluating the impact of age on the effectiveness of chemoimmunotherapy in patients with ES-SCLC.
Webb13 juli 2024 · Adults treated with high-dose chemotherapy and stem-cell or bone marrow transplantation should be offered a 3-drug combination of an NK 1 receptor antagonist, a 5-HT 3 receptor antagonist, and dexamethasone (Type: evidence based, benefits outweigh harms; Evidence quality: high; Strength of recommendation: strong). radio ljubic uzivoWebbEtoposide and cisplatin chemotherapy (EP) is a combination chemotherapy treatment used to treat different types of cancer. It is best to read this information with our general … radio ljubic uzivo preko internetaWebb10 apr. 2024 · Patients were eligible if they had: (i) biopsy-proven SCLC, (ii) stage IV disease, or (iii) treatment with platinum-etoposide chemotherapy alone (CT group) or in association with first-line PD-L1 inhibitors, atezolizumab, or durvalumab (CIT group). radio ljubic prnjavor onlineWebb5 dec. 2024 · Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen. Ann Oncol 1993; 4:579. Twelves CJ, Souhami RL, Harper PG, et al. The response of cerebral metastases in small cell lung cancer to systemic … radio ljubic uzivo prnjavorWebb11 apr. 2024 · All patients received platin-based chemotherapy with either carboplatin or cisplatin together with etoposide. At least one cycle of atezolizumab or durvalumab was administered, in most cases from the second or third cycle onwards. Immunotherapy with PD-L1 inhibitors was discontinued in case of adverse effects or disease progression. dragon ball super goku vs fuWebb5 apr. 2024 · This is a single arm, Phase II trial involving the use of atezolizumab plus platinum and etoposide for patients with locally advanced urothelial cancer. The primary … dragon ball super goku vs cumberWebb8 mars 2024 · Historically, cytotoxic chemotherapy consisting of platinum–etoposide or anthracycline-based regimens has demonstrated a high response rate, but early chemoresistance leads to a poor prognosis in advanced SCLC. Only a fraction of patients with limited-disease can be cured by chemo-radiotherapy. dragon ball super goku vs beerus